Clinical neuropathology practice guide 06-2012: MGMT testing in elderly glioblastoma patients – yes, but how?

Por Berghoff, Anna S., Preusser, Matthias
Publicado em 2012

In search of a target: PD-1 and PD-L1 profiling across glioma types

Por Berghoff, Anna S., Preusser, Matthias
Publicado no Neuro Oncol (2016)

Milestones of the last 10 years: CNS cancer

Por Marosi, Christine, Preusser, Matthias
Publicado no Memo (2017)

Targeted Therapies for Melanoma Brain Metastases

Por Berghoff, Anna S., Preusser, Matthias
Publicado no Curr Treat Options Neurol (2017)

Clinical Neuropathology Practice News 2-2013: immunohistochemistry pins IDH in glioma – molecular testing procedures under scrutiny

Por Preusser, Matthias, van den Bent, Martin
Publicado em 2013

Molecular biology of high-grade gliomas: what should the clinician know?

Por Hofer, Silvia, Rushing, Elisabeth, Preusser, Matthias, Marosi, Christine
Publicado em 2014

Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?

Por Preusser, Matthias, Berghoff, Anna S., Wick, Wolfgang, Weller, Michael
Publicado no Clin Neuropathol (2015)

Subcellular Localization of Disease-Associated Prion Protein in the Human Brain

Por Kovács, Gábor G., Preusser, Matthias, Strohschneider, Michaela, Budka, Herbert
Publicado em 2005

Clinical Neuropathology Practice News 4-2012: levels of evidence for brain tumor biomarkers

Por Berghoff, Anna Sophie, Stefanits, Harald, Heinzl, Harald, Preusser, Matthias
Publicado em 2012

Cancer immune cycle: a video introduction to the interaction between cancer and the immune system

Por Preusser, Matthias, Berghoff, Anna S, Thallinger, Christiane, Zielinski, Christoph C
Publicado no ESMO Open (2016)

Clinical neuropathology practice news 2-2012: BRAF V600E testing

Por Capper, David, Berghoff, Anna-Sophie, von Deimling, Andreas, Preusser, Matthias
Publicado em 2012

Expression of Telomeres in Astrocytoma WHO Grade 2 to 4: TERRA Level Correlates with Telomere Length, Telomerase Activity, and Advanced Clinical Grade

Por Sampl, Sandra, Pramhas, Sibylle, Stern, Christian, Preusser, Matthias, Marosi, Christine, Holzmann, Klaus
Publicado em 2012

Clinical Neuropathology Practice Guide 3-2013: levels of evidence and clinical utility of prognostic and predictive candidate brain tumor biomarkers

Por Berghoff, Anna S., Stefanits, Harald, Woehrer, Adelheid, Heinzl, Harald, Preusser, Matthias, Hainfellner, Johannes A.
Publicado em 2013

NephroCheck data compared to serum creatinine in various clinical settings

Por Pajenda, Sahra, Ilhan-Mutlu, Aysegül, Preusser, Matthias, Roka, Sebastian, Druml, Wilfred, Wagner, Ludwig
Publicado no BMC Nephrol (2015)

Prospects of immune checkpoint modulators in the treatment of glioblastoma

Por Preusser, Matthias, Lim, Michael, Hafler, David A., Reardon, David A., Sampson, John H.
Publicado no Nat Rev Neurol (2015)

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions

Por Bienkowski, Michal, Berghoff, Anna S., Marosi, Christine, Wöhrer, Adelheid, Heinzl, Harald, Hainfellner, Johannes A., Preusser, Matthias
Publicado no Clin Neuropathol (2015)

Frequent MGMT (0(6)-methylguanine-DNA methyltransferase) hypermethylation in long-term survivors of glioblastoma: a single institution experience

Por Baur, Martina, Preusser, Matthias, Piribauer, Maria, Elandt, Katarzyna, Hassler, Marco, Hudec, Marcus, Dittrich, Christian, Marosi, Christine
Publicado em 2010

NRAS and BRAF Mutations in Melanoma-Associated Nevi and Uninvolved Nevi

Por Tschandl, Philipp, Berghoff, Anna Sophie, Preusser, Matthias, Burgstaller-Muehlbacher, Sebastian, Pehamberger, Hubert, Okamoto, Ichiro, Kittler, Harald
Publicado em 2013

Influence of the American ODAC Statement on Austrian Bevacizumab Prescribing Practice for Metastatic Breast Cancer

Por Preusser, Matthias, Fülöp, Gerhard, Berghoff, Anna Sophie, Heinzl, Harald, Steger, Guenther G., Greil, Richard, Zielinski, Christoph C., Bartsch, Rupert
Publicado em 2012

CN-06 IS HYPOPITUITARISM CLINICALLY RELEVANT IN GLIOMA PATIENTS? - A CROSS-SELECTIONAL TRIAL IN PATIENTS WITH HIGH-GRADE GLIOMAS

Por Handisurya, Ammon, Ristl, Robin, Henzl, Harald, Kautzky-Willer, Alexandra, Dieckmann, Karin, Hainfellner, Johannes, Woehrer, Adelheid, Preusser, Matthias, Marosi, Christine
Publicado em 2014